Hamilton Thorne (TSE:HTL) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hamilton Thorne is set to be acquired by Astorg at CAD$2.25 per share, marking an enterprise value of about CAD$388 million, which is a significant premium over recent trading prices. The board of Hamilton Thorne has unanimously endorsed the deal as beneficial and financially fair to its shareholders. Astorg also plans to integrate Hamilton Thorne with Cook Medical’s ART product line post-acquisition.
For further insights into TSE:HTL stock, check out TipRanks’ Stock Analysis page.